Stockreport

Eli Lilly's COVID-19 treatment now authorized high-risk patients 'of any age' [MarketWatch]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF Authorization (EUA) for its bamlanivimab and etesevimab, taken together, to treat certain high-risk patients that are under the age of 12, even newborns. "With the FDA's [Read more]